ArticleSensors (Basel, Switzerland)2024
Segmentation of Low-Grade Brain Tumors Using Mutual Attention Multimodal MRI.
Article in Sensors (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Mamba-based brain tumor segmentation of incomplete multi-modal MR images.Quantitative imaging in medicine and surgery · 2026Article
- Enhanced brain tumor segmentation in medical imaging using multi-modal multi-scale contextual aggregation and attention fusion.Scientific reports · 2025Article
- Automated Brain Tumor MRI Segmentation Using ARU-Net with Residual-Attention Modules.Diagnostics (Basel, Switzerland) · 2025Article
- Multi-level channel-spatial attention and light-weight scale-fusion network (MCSLF-Net): multi-level channel-spatial attention and light-weight scale-fusion transformer for 3D brain tumor segmentation.Quantitative imaging in medicine and surgery · 2025Article
- Quantitative brain volumetry in neurological disorders: from disease mechanisms to software solutions.Polish journal of radiology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Early detection and precise characterization of brain tumors play a crucial role in improving patient outcomes and extending survival rates. Among neuroimaging modalities, magnetic resonance imaging (MRI) is the gold standard for brain tumor diagnostics due to its ability to produce high-contrast images across a variety of sequences, each highlighting distinct tissue characteristics. This study focuses on enabling multimodal MRI sequences to advance the automatic segmentation of low-grade astrocytomas, a challenging task due to their diffuse and irregular growth patterns. A novel mutual-attention deep learning framework is proposed, which integrates complementary information from multiple MRI sequences, including T2-weighted and fluid-attenuated inversion recovery (FLAIR) sequences, to enhance the segmentation accuracy. Unlike conventional segmentation models, which treat each modality independently or simply concatenate them, our model introduces mutual attention mechanisms. This allows the network to dynamically focus on salient features across modalities by jointly learning interdependencies between imaging sequences, leading to more precise boundary delineations even in regions with subtle tumor signals. The proposed method is validated using the UCSF-PDGM dataset, which consists of 35 astrocytoma cases, presenting a realistic and clinically challenging dataset. The results demonstrate that T2w/FLAIR modalities contribute most significantly to the segmentation performance. The mutual-attention model achieves an average Dice coefficient of 0.87. This study provides an innovative pathway toward improving segmentation of low-grade tumors by enabling context-aware fusion across imaging sequences. Furthermore, the study showcases the clinical relevance of integrating AI with multimodal MRI, potentially improving non-invasive tumor characterization and guiding future research in radiological diagnostics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.